| [1] SCHMIDT E W,RAVENTO-SUAREZ C,BIFANO M,et al.A cytotoxic cyclic peptide from the lithistid sponge scleritoderma nodosum[J].J.Nat.Prod.,2004,67(3):475-473.[2] SELLANES D,MANTA E,SERRA G.Toward the total synthesis of Scleritodermin A:preparation of the C1-N15 fragment[J].Tetrahedron Lett.,2007,48(5):1827-1830.[3] 崔永梅,南发俊.海洋环肽Scleritodermin A的全合成研究[C]//中国化学会第四届有机化学学术会议论文集,2005.[4] PEREZ L J,FAULKNER D J.Bistratamides E-J,modified cyclic hexapeptides from the Philippines ascidian lissoclinum bistratum[J].J.Nat.Prod.,2003,66(2):247-250.[5] RUDI A,CHILL L,AKNIN M,et al.Didmolamide A and B,two new cyclic hexapeptides from the marine ascidian didemnum molle[J].J.Nat.Prod.,2003,66(4):575-577.[6] YOU S L,Kelly J W.Highly efficient biomimetic total synthesis and structural verification of bistratamides E and J from Lissoclinum bistratum[J].Chem.Eur.J.,2004,10(1),71-75.[7] SHIN C,ABE C,YONEZAWA Y.Total synthesis of bistratamide G,a metabolite of the philippines ascidian lissoclinum bistratum,from dehydrotripeptides[J]. Chem. Lett.,2004,33(6):664-665.[8] NAKAMURA Y,OKUMURA K,KOJIMA M,et al.An expeditious synthesis of bistratamide H using a new fluorous protecting group[J].Tetrahedron Lett.,2006,47(2):239-243.[9] WILLIAMS P G,YOSHIDA W Y,MOORE R E,et al. Isolation and structure determination of obyanamide,a novel cytotoxic cyclic depsipeptide from the marine cyanobacterium Lyngbya confervoides[J].J.Nat.Prod.,2002,65(1):29-31.[10] ZHANG W,MA Z,MEI D,et al.Total synthesis and reassignment of stereochemistry of obyanamide[J]. Tetrahedron,2006,62(42):9966-9972.[11] LUESCH H,YOSHIDA W Y,MOORE R E,et al.Total structure determination of apratoxin A,a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscule[J].J.Am.Chem.Soc.,2001,123(23):5418-5423.[12] LUESCH H,YOSHIDA W Y,MOORE R E,et al.New apratoxins of marine cyanobacterial origin from Guam and Palau[J].Bioorg.Med.Chem.,2002,10(6):1973-1978.[13] CHEN J,FORSYTH C.Total synthesis of the marine cyanobacterial cyclodepsipeptide apratoxin A[J]. Proc.Nat.Acad.Sci.,2004,101(33):12067-12072.[14] DOI T,NUMAJIRI Y,MUNAKATA A,et al.Total synthesis of Apratoxin A[J].Org.Lett.,2006,8(3):531-534.[15] GAICH T,KARIG G,MARTIN H J,et al.New solutions to the C-12,13 stereoproblem of epothilones B and D; synthesis of a 12,13-diol-acetonide epothilone B analog[J]. Eur. J.Org.Chem.,2006,15:3372-3394.[16] WILSON R M,DANISHEFSKY S J.Small molecule natural products in the discovery of therapeutic agents:the synthesis connection[J].J.Org.Chem.,2006,71(22):8329-8351.[17] AHN J W,JANG K H,YANG H C,et al.Bithiazole metabolites from the myxobacterium myxococcus fulvus[J]. Chem.Pharm.Bull.,2007,55(3):477-479.[18] SANDLER J S,COLIN P L,KELLY M,et al.Cytotoxic macrolides from a new species of the deep-water marine sponge Leiodermatium[J].J.Org.Chem.,2006,71(19):7245-7251.[19] WRIGHT A E,BOTELHO J C,GUZMAN E,et al. Neopeltolide,a macrolide from a lithistid sponge of the family neopeltidae[J].J.Nat.Prod.,2007,70(3):412-416.[20] HEARN B R,ARSLANIAN R L,FU H,et al. Methanolysis products of disorazole A1[J].J.Nat.Prod.,2006,69(1):148-150.[21] ELNAKADY Y A,SASSE F,LUNSDORF H,et al. Disorazol A1,a highly effective antimitotic agent acting on tubulin polymerization and inducing apoptosis in mammalian cells[J].Biochem.Pharmacol.,2004,67(5):927-935.[22] HAUSTEDT L O,PANICKER S B,KLEINERT M,et al.Synthetic studies toward the disorazoles:synthesis of a masked northern half of disorazole D1 and a cyclopropane analog of the masked northern half of disorazole A1[J]. Tetrahedron,2003,59(35):6967-6977.[23] LI Y MM,Milne J C,Madison L L,et al.From peptide precursors to oxazole and thiazole-containing peptide antibiotics:mircrocin B17 synthase[J].Science,1996,274:1188-1193.[24] WALSH C T.Polyketide and nonribosomal peptide antibiotics:modularity and versatility[J].Science,2004,303:1805-1810.[25] IE Y,ITANI M,KARAKAWA M,et al.Air-stable n-type organic field-effect transistors based on carbonyl-bridged bithiazole derivatives[J].Adv.Funct.Mater.,2010,20(6):907-913.[26] ROMERO F A,DU W,HWANG I,et al.Potent and selective α-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme,fatty acid amide hydrolase[J]. J. Med.Chem.,2007,50(5):1058-1068.[27] HANNAN P C T,O'HANLON P J M.Fermentans infection treatment:WO9314752[P].1993-08-05.[28] ADAMCZEWSKI M,ARNOLD C,BECKER A,et al. Fungicide aminothiazole derivatives:WO2010012793[P]. 2010-02-04..[29] BAELL J B,BUI C T,COLMAN P,et al.Compounds and methods of use:WO 2010080478[P].2010-07-15.[30] CAROFF E,HILPERT K,HUBLER F,et al.Thiazole derivatives and their use as P2Y12 receptor antagonists:WO2010122504[P].2010-10-28.[31] JANSSEN B,KLING A,MULLER S,et al.1-Amino-3-phenyoxy propane derivatives as modulators for multi-drug resistance:WO9422842[P].1994-10-13.[32] MILLAN D S,PRAGER R H,BRAND C,et al.The synthesis and activity of oxazole and thiazole analogues of urocanic acid[J].Tetrahedron,2000,56(5):811-816.[33] NAN F,ZZUO J,WANG W,et al.Bisheterocycle tandem compounds useful as antiviral agents,the uses thereof and the compositions comprising such compounds:WO2006097030A1[P]. 2006-09-21.[34] COISH P D G,O'CONNOR S J,WICHENS P,et al.Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity:WO03037332[P]. 2003-05-08.[35] AISSAOUI H,BOSS C,KOBERSTEIN R,et al. Pyrrolidines and peperidines as orexin receptor antagonists:WO2009040730[P].2009-04-02.[36] RICE R L,RUSNAK J M,YOKOKAWA F,et al.A targeted library of small-molecule,tyrosine,and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation[J].Biochemistry,1997,36(50):15965-15974.[37] DUCRUET A P,RICE R L,TAMURA K,et al. Identification of new Cdc25 dual specificity phosphatase inhibitors in a targeted small molecule array[J]. Bioorg.Med.Chem.,2000,8(6):1451-1466.[38] NARUTO S,SUGANO Y,TATSUTA T,et al.Oxazole derivatives,their preparation and their use as cytokine inhibitors:WO02064558[P].2002-08-22.[39] LI X,MURRAY W V,MACIELAG M J,et al.Azole carboxamide inhibitors of bacterial type Ⅲ protein secretion systems:WO2005113522[P].2005-12-01.[40] READER J C.Pharmaceutical compounds:WO2010055304[P].2010-05-20. |
